Skip to main content
SpringerLink
Log in

The expanding clinical use of C-peptide radioimmunoassay

  • Review
  • Published:
Acta diabetologia latina Aims and scope Submit manuscript

Summary

C-peptide levels are in many ways a better measure of endogenous insulin secretion than peripheral insulin levels. C-peptide may be measured in either blood or urine. Perhaps the major advantage of measuring C-peptide levels is the ability to readily distinguish endogenous insulin levels in the presence of exogenous administration of insulin. Early C-peptide immunoassays were troubled by lack of sensitivity. This problem has now been overcome, and it is possible to measure C-peptide values down to extremely low levels. The clinical indications for C-peptide measurement include diagnosis of insulinoma and differentiation from factitious hypoglycemia, follow-up of pancreatectomy and evaluation of viability of islet cell transplants. Recently these indications have been dramatically expanded to permit evaluation of insulin dependence in maturity onset diabetes mellitus.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Similar content being viewed by others

References

  1. Ashby J. P., Frier B. M.: Circulating C-peptide: measurement and clinical application — Ann. clin. Biochem.18, 125, 1981.

    PubMed  CAS  Google Scholar 

  2. Beischer W., Kerner W., Raptis S., Keller L., Beischer B., Pfeiffer E. F.: Insulin therapy in relation to circulating C-peptide levels — Diabetes27 (Suppl. 1), 235, 1978.

    PubMed  CAS  Google Scholar 

  3. Blix P. M., Boddie-Willis C., Landau R. L., Rochman H., Rubenstein A. H.: Urinary C-peptide: an indicator of beta cell secretion under different metabolic conditions — J. clin. Endocr.54, 574, 1982.

    PubMed  CAS  Google Scholar 

  4. Chiles R., Tzagournis M.: Excessive serum insulin response to oral glucose in obesity and mild diabetes. Studies of 501 patients — Diabetes19, 458, 1970.

    PubMed  CAS  Google Scholar 

  5. Doar J. W. H., Wilde C. E., Thompson M. E., Sewell P. F. J.: Influence of treatment with diet alone on oral glucose tolerance test and plasma sugar and insulin in patients with maturity onset diabetes mellitus — Lanceti, 1263, 1975.

    Article  Google Scholar 

  6. Faber O. K., Binder C.: C-peptide response to glucagon. A test for the residual beta cell function in diabetes mellitus — Diabetes26, 605, 1977.

    Article  PubMed  CAS  Google Scholar 

  7. Faber O. K., Binder C., Markussen J., Heding L. G., Naithani V. F., Kuzuya H., Blix P. M., Horwitz D. L., Rubenstein A. H.: Characterization of seven C-peptide antisera — Diabetes27 (Suppl. 1), 170, 1978.

    PubMed  CAS  Google Scholar 

  8. Faber O. K., Hagen C., Binder C., Markussen J., Naithani V. K., Blix P. M., Kuzuya H., Horwitz D. L., Rubenstein A. H., Rossing N.: Kinetics of human C-peptide in normal and diabetic subjects — J. clin Invest.62, 197, 1978.

    PubMed  CAS  Google Scholar 

  9. Faber O. K., Kehlet H., Madsbad S., Binder C.: Kinetics of human C-peptide in man — Diabetes27 (Suppl. 1), 207, 1978.

    PubMed  CAS  Google Scholar 

  10. Faber O. K., Markussen J., Naithani V. K., Binder C.: Systematic production of antisera to synthetic benzyloxycarbonyl C-peptide — Hoppe-Seylers Z. physiol. Chem.357, 751, 1978.

    Google Scholar 

  11. Fink G., Cresto J. C., Gutman R. A., Lavine R. L., Rubenstein A. H. Recant L.: Plasma proinsulin like material in insulin treated diabetics — Hormone metab. Res.6, 439, 1974.

    CAS  Google Scholar 

  12. Genuth S. M.: Plasma insulin and glucose profiles in normal, obese, and diabetic persons — Ann. intern. Med.79, 812, 1973.

    PubMed  CAS  Google Scholar 

  13. Gutman R. A., Lazarus N. R., Penhos J. C., Fajans S., Recant L.: Circulating proinsulin like material in patients with functioning insulinomas — New Engl. J. Med.284, 1003, 1971.

    Article  PubMed  CAS  Google Scholar 

  14. Hadden D. R., Montgomery D. A. D., Skelley R. J., Trimble E. R., Weaver J. A., Wilson E. A., Buchanan K. D.: Maturity onset diabetes mellitus: response to intensive dietary management — Brit. med. J.iii, 276, 1975.

    Google Scholar 

  15. Heding L. G.: Insulin, C-peptide, and proinsulin in non-diabetics and insulin treated diabetics. Characterization of the proinsulin in insulin treated diabetics — Diabetes27 (Suppl. 1), 178, 1978.

    PubMed  CAS  Google Scholar 

  16. Heding L. G., Ludvigsson J.: Human proinsulin in insulin treated juvenile diabetics — Acta paediat. (Uppsala)27 (Suppl.), 48, 1977.

    Google Scholar 

  17. Heding L. G., Rasmussen S. M.: Human C-peptide in normal and diabetic subjects — Diabetologia11, 201, 1975.

    Article  PubMed  CAS  Google Scholar 

  18. Heding L. G., Turner R. C., Harris E.: C-peptide, proinsulin and insulin responses to fish-insulin induced hypoglycaemia in the diagnosis of insulinomas — Diabetes24 (Suppl. 2), 412, 1975; abstract # 80.

    Google Scholar 

  19. Hoekstra J. B. L., Van Rijn H. J. M., Thijsson J. H. H., Erkelens D. W.: C-peptide reactivity as a measure of insulin dependency in obese diabetic patients treated with insulin — Diabetes Care5, 585, 1982.

    Article  PubMed  CAS  Google Scholar 

  20. Horwitz D. L., Kuzuya H., Rubenstein A. H.: Circulating serum C-peptide. A brief review of diagnostic implications — New Engl. J. Med.295, 207, 1976.

    Article  PubMed  CAS  Google Scholar 

  21. Horwitz D. L., Rubenstein A. H., Katz A. I.: Quantitation of human pancreatic beta-cell function by immunoassay of C-peptide in urine — Diabetes26, 20, 1977.

    Article  Google Scholar 

  22. Horwitz D. L., Rubenstein A. H., Mako M. E., Cruz A., Blix P. M.: C-peptide in conditions other than diabetes mellitus — Diabetes27 (Suppl. 1), 267, 1978.

    PubMed  CAS  Google Scholar 

  23. Horwitz D. L., Starr J. I., Mako M. E., Blackard W. S., Rubenstein A. H.: Proinsulin, insulin and C-peptide concentration in human portal and peripheral blood — J. clin. Invest.55, 1278, 1975.

    PubMed  CAS  Google Scholar 

  24. Johnston D. G., Alberti K. G. M. M., Wright R., Smith-Laing G., Stewart A. M., Sherlock S., Faber O. K., Binder C.: C-peptide and insulin in liver disease — Diabetes27 (Suppl. 1), 201, 1978.

    PubMed  CAS  Google Scholar 

  25. Kaneko T., Munemura M., Oka H., Oda T., Suzuki S., Yasuda H., Yanaihara N., Nakagawa S., Makebe K.: Demonstration of C-peptide immunoreactivity in various body fluids and clinical evaluation of the determination of urinary C-peptide immunoreactivity — Endocr. jap.22, 207, 1975.

    CAS  Google Scholar 

  26. Kaneko T., Oka H., Munemura M., Oda T., Yamashita K., Suzuki S., Yanaihara N., Hashimoto S., Yanaihara C.: Radioimmunoassay of human proinsulin C-peptide using synthetic human connecting peptide — Endocr. jap.21, 141, 1974.

    CAS  Google Scholar 

  27. Katz A. L., Rubenstein A. H.: Metabolism of proinsulin, insulin and C-peptide in the rat — J. clin. Invest.52, 1113, 1973.

    PubMed  CAS  Google Scholar 

  28. Kühl C., Faber O. K., Hornnes P., Jensen S. L.: C-peptide metabolism and the liver — Diabetes27 (Suppl. 1), 197, 1978.

    PubMed  Google Scholar 

  29. Kuzuya H., Blix P. M., Horwitz D. L., Rubenstein A. H., Steiner D. F., Binder C., Faber O. K.: Heterogeneity of circulating C-peptide — J. clin. Endocr.44, 952, 1977.

    Article  PubMed  CAS  Google Scholar 

  30. Kuzuya H., Blix P. M., Horwitz D. L., Steiner D. F., Rubenstein A. H.: Determination of free and total insulin and C-peptide in insulin treated diabetes — Diabetes26, 22, 1977.

    Article  PubMed  CAS  Google Scholar 

  31. Kuzuya H., Chance R. E., Steiner D. F., Rubenstein A. H.: On the preparation and characterization of standard materials for natural human proinsulin and C-peptide — Diabetes27 (Suppl. 1), 161, 1978.

    PubMed  CAS  Google Scholar 

  32. Kuzuya H., Matsuda A., Sakamoto Y., Tanabshi S., Kajinuma H.: C-peptide immunoreactivity (CPR) in urine — Diabetes27 (Suppl. 1), 210, 1978.

    PubMed  CAS  Google Scholar 

  33. Matsuda A., Kuzuya T.: Urine C-peptide after recovery from diabetic ketoacidosis. An index of insulin dependency — Diabetes Care5, 581, 1982.

    Article  PubMed  CAS  Google Scholar 

  34. Meistas M. J., Rendell M., Marcolis S. T., Kowarski A. A.: Estimation of the secretion rate of insulin from the urinary excretion rate of C-peptide: study in obese and diabetic subjects — Diabetes31, 449, 1982.

    Article  PubMed  CAS  Google Scholar 

  35. Melani F., Rubenstein A. H., Oyer P. E., Steiner D. F.: Identification of C-peptide in human serum by a specific immunoassay — Proc. nat. Acad. Sci. (Wash.)67, 148, 1970.

    Article  CAS  Google Scholar 

  36. Naithani V. F., Dechesne M., Markussen J., Heding L. G.: Improved synthesis of human proinsulin C-peptide and its benzylcarbonyl derivative. Circular dichronism and studies of human C-peptide — Hoppe-Seylers Z. physiol. Chem.356, 997, 1975.

    PubMed  CAS  Google Scholar 

  37. Nakagawa S., Nakayama H., Sazaki T., Yoshino K., Yu Y. Y., Shinozaki K., Aoki S., Mashimo K.: A simple method for the determination of serum free insulin levels in insulin treated patients — Diabetes22, 590, 1973.

    PubMed  CAS  Google Scholar 

  38. Newburgh L. H.: Control of hyperglycemia of obese diabetics by weight reduction — Ann. intern. Med.17, 935, 1942.

    CAS  Google Scholar 

  39. Oyama H., Horino M., Matsumara S., Kobayashi K., Suetsuga N.: Immunological half-life of porcine proinsulin C-peptide — Hormone metab. Res.7, 520, 1975.

    CAS  Google Scholar 

  40. Perley M. J., Kipnis D. M.: Plasma insulin responses to oral and intravenous glucose. Studies in normal and diabetic subjects — J. clin. Invest.46, 1954, 1967.

    Article  PubMed  CAS  Google Scholar 

  41. Rendell M.: C-peptide levels as a criterion in treatment of maturity onset diabetes — J. clin. Endocr. (In press).

  42. Rendell M., Drew H. M., Hamilton R. G., Adkinson N. F. Jr.: Exacerbation of diabetes mellitus by antibodies induced by exogenous insulin — Amer. J. med. Sci.282, 18, 1981.

    Article  PubMed  CAS  Google Scholar 

  43. Rendell M., Ross D. A., Drew H. M., Zarriello J.: Endogenous insulin secretion measured by C-peptide in maturity onset diabetes controllable by diet alone — Arch. intern. Med.141, 1617, 1981.

    Article  PubMed  CAS  Google Scholar 

  44. Rendell M., Zarriello J., Drew H. M., Dranbauer B., Wilson G., Waud G., Ross D. A.: Recovery from decompensated maturity onset diabetes mellitus: studies of C-peptide secretion — Diabetes Care4, 354, 1981.

    Article  PubMed  CAS  Google Scholar 

  45. Rubenstein A. H.: The significance of immunoassayable urinary insulin in man — J. Amer. med. Ass.209, 254, 1969.

    Article  CAS  Google Scholar 

  46. Rubenstein A. H., Welbouren W. P., Mako M., Melani F., Steiner D. F.: Comparative immunology of bovine, porcine and human proinsulins and C-peptides — Dibetes19, 546, 1970.

    CAS  Google Scholar 

  47. Sandler R., Horwitz D. L., Rubenstein A. H., Kuzuya H.: Hypoglycemia and endogenous hyperinsulinism complicating diabetes mellitus. Application of the C-peptide assay to diagnosis and therapy — Amer. J. Med.59, 730, 1975.

    Article  PubMed  CAS  Google Scholar 

  48. Savage P. L., Bennion L. J., Flock E. V., Nagulesparan M., Mott D., Roth J., Unger R., Bennet P. H.: Diet induced improvement of abnormalities in insulin and glucagon secretion and in insulin receptor binding in diabetes mellitus — J. clin. Endocr.48, 999, 1979.

    Article  PubMed  CAS  Google Scholar 

  49. Scarlett J. A., Mako M. E., Rubenstein A. H., Blix P. M., Goldman J., Horwitz D. L., Tager H., Jaspan J. B., Stjernholm M. E., Olefsky J. M.: Factitious hypoglycemia: diagnosis by measurement of serum C-peptide immunoreactivity and insulin binding antibodies — New Engl. J. Med.297, 1029, 1977.

    Article  PubMed  CAS  Google Scholar 

  50. Service J. F., Horwitz D. L., Rubenstein A. H., Kuzuya H., Mako M. E., Reynolds C., Molnar G. D.: C-peptide suppression test for insulinoma — J. Lab. clin. Med.90, 180, 1977.

    PubMed  CAS  Google Scholar 

  51. Service J. F., Rubenstein A. H., Horwitz D. L.: C-peptide analysis in diagnosis of factitious hypoglycemia in an insulin dependent diabetic — Mayo Clin. Proc.50, 697, 1975.

    PubMed  CAS  Google Scholar 

  52. Stoll R. W., Touber J. L., Menahan L. A., Williams R. H.: Clearance of porcine insulin, proinsulin, and C-peptide by the isolated rat liver — Proc. Soc. exp. Biol. (N. Y.)3, 894, 1970.

    Google Scholar 

  53. Turkington R. W., Estkowski A., Link M.: Secretion of insulin or C-peptide. A predictor of insulin dependence in obese ‘diabetics’. Arch. intern. Med.142, 1102, 1982.

    Article  PubMed  CAS  Google Scholar 

  54. Welborn T. A., Garcia-Webb P., Bonser A. M.: Basal C-peptide in the discrimination of type I from type II diabetes — Diabetes Care4, 616, 1981.

    Article  Google Scholar 

  55. Yalow R. S., Berson S.: Immunoassay of endogenous plasma insulin in man — J. clin. Invest.39, 1157, 1960.

    Article  PubMed  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. The Johns Hopkins University School of Medicine, Wyman Park Health System, Inc., Baltimore

    Marc Rendell

Authors
  1. Marc Rendell
    View author publications

    You can also search for this author in PubMed Google Scholar

Rights and permissions

Reprints and permissions

About this article

Cite this article

Rendell, M. The expanding clinical use of C-peptide radioimmunoassay. Acta diabet. lat 20, 105–113 (1983). https://doi.org/10.1007/BF02624911

Download citation

  • Received:

  • Issue Date:

  • DOI: https://doi.org/10.1007/BF02624911

Key-words

Search

Navigation